PMID- 27757293
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240326
IS  - 2159-2896 (Print)
IS  - 2159-2896 (Electronic)
IS  - 2159-2896 (Linking)
VI  - 11
IP  - 5
DP  - 2016 Oct
TI  - PERTINENT DRY NEEDLING CONSIDERATIONS FOR MINIMIZING ADVERSE EFFECTS - PART TWO.
PG  - 810-819
AB  - BACKGROUND: Dry needling (DN) is an evidence based treatment technique that is 
      accepted and used by physical therapists in the United States. This clinical 
      commentary is the second in a two-part series outlining some of the pertinent 
      anatomy and other issues that are needed for optimal utilization of this 
      treatment modality. Part one was an overview of the thorax with a summary of 
      reported adverse effects (AEs) and the underlying anatomy that could be used to 
      minimize patient risk. As is the case with any intervention, the technique of dry 
      needling has some inherent patient risk. The incidence of AEs with this procedure 
      is typically low, ranging from zero to approximately 10 percent. Knowledge of the 
      underlying anatomy can be a key factor associated with decreasing the likelihood 
      of an AE. PURPOSE/OBJECTIVE: The second part of this clinical commentary goes 
      beyond the thorax, to explore the anatomy associated with dry needling the 
      abdomen, pelvis, and back. In the abdomen, pelvis and back, dry needling can 
      penetrate the peritoneal cavity or adjacent organs, resulting in AEs. A 
      physiological reaction that is an AE secondary to a needle insertion, pain or 
      fear, is an autonomic vasovagal response. Additionally, suggestions for dealing 
      with the fearful patient, the obese patient, universal precautions, and other 
      clinical considerations, are discussed. The purpose of parts one and part two of 
      this clinical commentary is to minimize the risk of a dry needling AE. 
      CONCLUSIONS/IMPLICATIONS: Dry needling is an effective adjunctive treatment 
      procedure that is within the recognized scope of practice of the physical 
      therapist. An evidence-based implementation of the procedure must be based on a 
      thorough understanding of the underlying anatomy and the potential risks, with 
      risks communicated to patients via informed consent. LEVEL OF EVIDENCE: Level 5.
FAU - Halle, John S
AU  - Halle JS
AD  - Belmont University, Nashville, TN, USA.
FAU - Halle, Rob J
AU  - Halle RJ
AD  - US Army-Baylor University Post-Professional Sports Medicine, Physical Therapy 
      Doctoral Fellowship, Keller Army Community Hospital, West Point, NY, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Int J Sports Phys Ther
JT  - International journal of sports physical therapy
JID - 101553140
PMC - PMC5046974
OTO - NOTNLM
OT  - Adverse effect
OT  - anatomy
OT  - dry needling
OT  - informed consent
OT  - pneumothorax
OT  - vasovagal response
EDAT- 2016/10/21 06:00
MHDA- 2016/10/21 06:01
PMCR- 2016/10/01
CRDT- 2016/10/21 06:00
PHST- 2016/10/21 06:00 [pubmed]
PHST- 2016/10/21 06:01 [medline]
PHST- 2016/10/21 06:00 [entrez]
PHST- 2016/10/01 00:00 [pmc-release]
PST - ppublish
SO  - Int J Sports Phys Ther. 2016 Oct;11(5):810-819.